Scholarlink

Background <p>Acral melanoma (AM), accounting for ~50% of melanomas in Asian populations, exhibits far poorer immunotherapy response (anti-PD-1 ORR &lt; 20%) than cutaneous melanoma (CM, ~43.7%). While the tumor microenvironment (TME) plays a pivotal role in immunotherapy resistance, previous studies mainly focused on immune cells, neglecting stromal components like pericytes—creating a critical knowledge gap in understanding AM’s therapeutic refractoriness.</p> Methods <p>We integrated multiple single-cell transcriptomic datasets from 31 acral melanoma, 13 cutaneous melanoma and 35 normal skin samples. Comprehensive bioinformatics analyses including cell type annotation, differential expression, gene functional enrichment, and cell-cell interaction analysis, were performed to delineate the tumor microenvironment differences between acral and cutaneous melanoma. Key findings were validated using spatial transcriptomics, bulk RNA-seq datasets, and functional assays including qPCR and western blot.</p> Results <p>AM had a more immunosuppressive TME, enriched in collagen-secreting RGS5<sup>+</sup>/COL3A1<sup>+</sup> pericytes that co-localized with KDR<sup>+</sup>/PODXL<sup>+</sup> endothelial cells, associated with vascular abnormalities and hypoxia. These collagen-secreting RGS5<sup>+</sup>/COL3A1<sup>+</sup> pericytes (enriched in AM) were significantly negatively correlated with the infiltration ratio of CD8<sup>+</sup> tumor-infiltrating lymphocytes (TILs); moreover, in immunotherapy cohorts, high expression of the collagen-secreting pericyte marker RGS5 was associated with poorer response to immune checkpoint blockade (ICB) treatment. We also identified a hypoxia-related NECTIN2-TIGIT immunosuppressive axis: hypoxia upregulated NECTIN2 on multiple cells, interacting with TIGIT on T cells to potentially exacerbate dysfunction.</p> Conclusions <p>This study provides insights into vascular-stromal features associated with immunotherapy resistance in AM, highlighting RGS5<sup>+</sup>/COL3A1<sup>+</sup> pericytes and the NECTIN2-TIGIT axis as targets, and guides development of effective combination immunotherapies for AM.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Single-cell profiling uncovers a hypoxia-vascular-immune axis underlying poor immunotherapy response in acral versus cutaneous melanoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月7日

查看全文
  • Qian Dong,
  • Yiming Zhang,
  • Fuchu He,
  • Aihua Sun

摘要

Background

Acral melanoma (AM), accounting for ~50% of melanomas in Asian populations, exhibits far poorer immunotherapy response (anti-PD-1 ORR < 20%) than cutaneous melanoma (CM, ~43.7%). While the tumor microenvironment (TME) plays a pivotal role in immunotherapy resistance, previous studies mainly focused on immune cells, neglecting stromal components like pericytes—creating a critical knowledge gap in understanding AM’s therapeutic refractoriness.

Methods

We integrated multiple single-cell transcriptomic datasets from 31 acral melanoma, 13 cutaneous melanoma and 35 normal skin samples. Comprehensive bioinformatics analyses including cell type annotation, differential expression, gene functional enrichment, and cell-cell interaction analysis, were performed to delineate the tumor microenvironment differences between acral and cutaneous melanoma. Key findings were validated using spatial transcriptomics, bulk RNA-seq datasets, and functional assays including qPCR and western blot.

Results

AM had a more immunosuppressive TME, enriched in collagen-secreting RGS5+/COL3A1+ pericytes that co-localized with KDR+/PODXL+ endothelial cells, associated with vascular abnormalities and hypoxia. These collagen-secreting RGS5+/COL3A1+ pericytes (enriched in AM) were significantly negatively correlated with the infiltration ratio of CD8+ tumor-infiltrating lymphocytes (TILs); moreover, in immunotherapy cohorts, high expression of the collagen-secreting pericyte marker RGS5 was associated with poorer response to immune checkpoint blockade (ICB) treatment. We also identified a hypoxia-related NECTIN2-TIGIT immunosuppressive axis: hypoxia upregulated NECTIN2 on multiple cells, interacting with TIGIT on T cells to potentially exacerbate dysfunction.

Conclusions

This study provides insights into vascular-stromal features associated with immunotherapy resistance in AM, highlighting RGS5+/COL3A1+ pericytes and the NECTIN2-TIGIT axis as targets, and guides development of effective combination immunotherapies for AM.